HACE1 is downregulated in multiple cancer types due to allelic loss or promoter methylation, such as Wilms’ tumor, gastric cancer, lymphoma, hepatocellular carcinoma, breast cancer, neuroblastoma, advanced colorectal cancer, etc. [23,24,25,26,27,28,29]. This evidence concerns the gene HACE1 and breast carcinoma.